Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Eliquis (apixaban) and Pradaxa (dabigatran) are both blood thinners used to prevent and treat blood clots, but they work in different ways. Eliquis is typically taken twice daily and has an FDA-approved generic version that may not be available until 2026. Pradaxa is also taken twice daily but doesn’t have a generic version available. Eliquis is considered a first-choice treatment for preventing stroke in people with nonvalvular atrial fibrillation and might be safer for those with kidney problems. Pradaxa, on the other hand, requires careful use in people with kidney problems and has a higher risk of stomach bleeding, especially in those over 75. Both medications can cause bleeding, but Pradaxa has an available antidote in case of emergency.
Eliquis (apixaban)
Dabigatran (Pradaxa)
Eliquis (apixaban)
Dabigatran (Pradaxa)
Summary of Eliquis vs. Pradaxa
Summary for Direct-acting oral anticoagulant (DOAC)
Dabigatran etexilate mesylate, also known by its brand name, Pradaxa, is a type of anticoagulant blood thinner that treats and prevents certain types of blood clots in people ages 8 years and older. It's also used to lower the risk of stroke and blood clots in people with atrial fibrillation (AFib). The dosing can differ based on why you need the medication, but it's typically taken by mouth twice a day. Side effects include stomach upset and bleeding. For people who experience serious bleeding with this medication, there's an antidote medication called Praxbind (idarucizumab) that reverses its effects.